Cohance Lifesciences shareholders back Umang Vohra as Chairman and Group CEO
Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy
Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy
Samelisant will be the centerpiece of Suven’s scientific presence
Cervical cancer remains one of the leading causes of cancer deaths among women in India
The decision was driven by results from the Phase III CAPItello-281 trial,
Health Ministry reviews progress, highlights targeted interventions in high-burden states, and calls for stronger surveillance and stigma reduction to achieve a leprosy-free India
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
Two-year collaboration aims to strengthen primary healthcare systems, generate real-world evidence, and support responsible adoption of AI and digital health technologies across South-East Asia
The regulatory decision follows promising results from RIVER-81
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
MeRT becomes one of the few FDA-cleared neuromodulation therapies for PTSD, using EEG biomarkers and AI to personalize treatment for patients with treatment-resistant symptoms
Subscribe To Our Newsletter & Stay Updated